Most cited papers in Ocular Diseases and Behçet’s Syndrome
What are the most cited papers in Ocular Diseases and Behçet’s Syndrome?
The most cited paper in Ocular Diseases and Behçet’s Syndrome is "Ranibizumab for Neovascular Age-Related Macular Degeneration" (Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al., 2006), with 5,931 citations. Next come "Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop" (4,424) and "Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration" (2,681).
Showing 50 of 99 papers. Every paper with more than 594 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Ranibizumab for Neovascular Age-Related Macular Degeneration Philip J. Rosenfeld, David M. Brown, Jeffrey S. Heier et al. · New England Journal of Medicine | 4 Oct 2006 | 5,931 |
| 2 | Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop Douglas A. Jabs, Robert Burton Nussenblatt, James Todd Rosenbaum · American Journal of Ophthalmology | 19 Jul 2005 | 4,424 |
| 3 | Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group · New England Journal of Medicine | 28 Apr 2011 | 2,681 |
| 4 | Revised diagnostic criteria for neuromyelitis optica Dean M. Wingerchuk, Vanda A. Lennon, Sean Joseph Pittock et al. · Neurology | May 2006 | 2,585 |
| 5 | Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration Jonathan L. Haines, Michael A. Hauser, Silke Schmidt et al. · Science | 10 Mar 2005 | 2,436 |
| 6 | 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts Caroline H. Shiboski, Stephen C. Shiboski, Raphaèle Séror et al. · Arthritis & Rheumatology | 26 Oct 2016 | 1,993 |
| 7 | Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration Daniel Francis Martin, Maureen G. Maguire, Stuart L. Fine et al. · Ophthalmology | May 2012 | 1,726 |
| 8 | Ranibizumab for Diabetic Macular Edema Quan Dong Nguyen, David M. Brown, Dennis M. Marcus et al. · Ophthalmology | 11 Feb 2012 | 1,625 |
| 9 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema The Diabetic Retinopathy Clinical Research Network · New England Journal of Medicine | 18 Feb 2015 | 1,615 |
| 10 | Behçet's Disease Tsuyoshi Sakane, Mitsuhiro Takeno, Noboru Suzuki et al. · New England Journal of Medicine | 21 Oct 1999 | 1,612 |
| 11 | Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology Eva Vanessa Schrezenmeier, Thomas Dörner · Nature Reviews Rheumatology | 7 Feb 2020 | 1,519 |
| 12 | The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria International Team for the Revision of the International Criteria for Behçet's D et al. · Journal of the European Academy of Dermatology and Venereology | 26 Feb 2013 | 1,493 |
| 13 | Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema Michael J. Elman, Lloyd Paul Aiello, Roy W. Beck et al. · Ophthalmology | 29 Apr 2010 | 1,440 |
| 14 | A Pilot Study of Enhanced Depth Imaging Optical Coherence Tomography of the Choroid in Normal Eyes Ron Margolis, Richard F. Spaide · American Journal of Ophthalmology | 22 Feb 2009 | 1,365 |
| 15 | A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis Roy W. Beck et al. · New England Journal of Medicine | 27 Feb 1992 | 1,357 |
| 16 | The RESTORE Study Paul Mitchell, Francesco Maria Bandello, Ursula Margarethe Schmidt-Erfurth et al. · Ophthalmology | Apr 2011 | 1,338 |
| 17 | Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study David M. Brown, Mark Michels, Peter K. Kaiser et al. · Ophthalmology | 31 Dec 2008 | 1,323 |
| 18 | Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis Daniel J. Lovell, Edward H. Giannini, Andreas Otto Reiff et al. · New England Journal of Medicine | 16 Mar 2000 | 1,259 |
| 19 | Ranibizumab for Macular Edema following Central Retinal Vein Occlusion David M. Brown, Peter A. Campochiaro, Rishi P. Singh et al. · Ophthalmology | 10 Apr 2010 | 1,160 |
| 20 | Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature Russell W. Read, Gary N. Holland, Narsing A. Rao et al. · American Journal of Ophthalmology | May 2001 | 1,137 |
| 21 | Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema David S. Boyer, Young Hee Yoon, Rubens Belfort et al. · Ophthalmology | 4 Jun 2014 | 1,137 |
| 22 | Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis Loı̈c Guillevin et al. · New England Journal of Medicine | 5 Nov 2014 | 1,100 |
| 23 | Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion Julia A. Haller, Francesco Maria Bandello, Rubens Belfort et al. · Ophthalmology | 26 Apr 2010 | 1,076 |
| 24 | Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology | 27 Feb 2016 | 1,055 |
| 25 | Mechanisms of Age-Related Macular Degeneration Jayakrishna Ambati, Benjamin J. Fowler · Neuron | Jul 2012 | 1,038 |
| 26 | Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON Soraya Rofagha, Robert B. Bhisitkul, David S. Boyer et al. · Ophthalmology | 3 May 2013 | 1,028 |
| 27 | Differing Lymphokine Profiles of Functional Subsets of Human CD4 and CD8 T Cell Clones Padmini Salgame, John S. Abrams, Carol Clayberger et al. · Science | 11 Oct 1991 | 1,015 |
| 28 | Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel Douglas A. Jabs, James Todd Rosenbaum, Charles Stephen Foster et al. · American Journal of Ophthalmology | Oct 2000 | 999 |
| 29 | Heparin treatment in sinus venous thrombosis K. M. Einhäupl, Arno Villringer, S. Mehraein et al. · The Lancet | Sep 1991 | 997 |
| 30 | Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial David Winston Kimberlin, Chin‐Yu Lin, Pablo J. Sánchez et al. · The Journal of Pediatrics | Jul 2003 | 988 |
| 31 | An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration Anne E. Fung, Geeta A. Lalwani, Philip J. Rosenfeld et al. · American Journal of Ophthalmology | 28 Mar 2007 | 976 |
| 32 | ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY OF THE CHOROID IN CENTRAL SEROUS CHORIORETINOPATHY Yutaka Imamura, Takamitsu Fujiwara, Ron Margolis et al. · Retina | Nov 2009 | 973 |
| 33 | Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 Mark Ellsworth Kleinman et al. · Nature | 26 Mar 2008 | 929 |
| 34 | Causes and frequency of blindness in patients with intraocular inflammatory disease. Aniki Rothová, M S Suttorp-van Schulten, W F Treffers et al. · British Journal of Ophthalmology | Apr 1996 | 913 |
| 35 | Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration Philip J. Rosenfeld, Andrew A. Moshfeghi, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina | Jul 2005 | 907 |
| 36 | Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis Fabrizio De Benedetti et al. · New England Journal of Medicine | 19 Dec 2012 | 888 |
| 37 | A Variable-dosing Regimen with Intravitreal Ranibizumab for Neovascular Age-related Macular Degeneration: Year 2 of the PrONTO Study Geeta A. Lalwani, Philip J. Rosenfeld, Anne E. Fung et al. · American Journal of Ophthalmology | 20 Apr 2009 | 886 |
| 38 | A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis Peter Brex, Olga Ciccarelli, J. I. O’Riordan et al. · New England Journal of Medicine | 17 Jan 2002 | 866 |
| 39 | Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration Stratis Avraméas, Thérèse Ternynck · Immunochemistry | Dec 1971 | 864 |
| 40 | Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 Carl D. Regillo, David M. Brown, Prema Abraham et al. · American Journal of Ophthalmology | 28 Jan 2008 | 863 |
| 41 | TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 Ahjoku Amadi‐Obi, Cheng‐Rong Yu, Xuebin Liu et al. · Nature Medicine | 13 May 2007 | 862 |
| 42 | Incidence and prevalence of uveitis in Northern California The Northern California Epidemiology of Uveitis Study David C. Gritz · Ophthalmology | 27 Feb 2004 | 854 |
| 43 | Acquired Immune Deficiency Syndrome Gary N. Holland, Jay S. Pepose, Thomas H. Pettit et al. · Ophthalmology | Aug 1983 | 843 |
| 44 | Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials David M. Brown, Quan Dong Nguyen, Dennis M. Marcus et al. · Ophthalmology | 22 May 2013 | 831 |
| 45 | Intravitreal Aflibercept for Diabetic Macular Edema Jean‐François Korobelnik et al. · Ophthalmology | 8 Jul 2014 | 822 |
| 46 | Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration Ursula Margarethe Schmidt-Erfurth et al. · Ophthalmology | 29 Sep 2013 | 822 |
| 47 | 2018 update of the EULAR recommendations for the management of Behçet's syndrome Gülen Hatemi et al. · Annals of the Rheumatic Diseases | 6 Apr 2018 | 817 |
| 48 | Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy Robert L. Avery, Joel A. Pearlman, Dante J. Pieramici et al. · Ophthalmology | Oct 2006 | 803 |
| 49 | Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk Andrea Rivera, Sheila A. Fisher, Lars G. Fritsche et al. · Human Molecular Genetics | 20 Sep 2005 | 795 |
| 50 | Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients G. Akman‐Demir, Piraye Serdaroglu, B. Taşcı · Brain | Nov 1999 | 792 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.